Literature DB >> 29706819

Acute myocardial infarction triggered by use of synthetic cannabis.

Brooke Mills1, Emma Dishner1, Carlos E Velasco2.   

Abstract

A young woman presented with an anterior ST elevation myocardial infarction shortly after synthetic cannabis use. This report highlights the cardiovascular risks of these drugs.

Entities:  

Keywords:  K2; myocardial infarction; synthetic cannabinoids

Year:  2018        PMID： 29706819      PMCID： PMC5914480          DOI： 10.1080/08998280.2017.1416243

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  9 in total

1.  A survey study to characterize use of Spice products (synthetic cannabinoids).

Authors:  Ryan Vandrey; Kelly E Dunn; Jeannie A Fry; Elizabeth R Girling
Journal:  Drug Alcohol Depend       Date:  2011-08-10       Impact factor: 4.492

2.  K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.

Authors:  Rita G McKeever; David Vearrier; Dorian Jacobs; Gregory LaSala; Jolene Okaneku; Michael I Greenberg
Journal:  J Med Toxicol       Date:  2015-03

3.  Myocardial infarction associated with use of the synthetic cannabinoid K2.

Authors:  Arshid Mir; Adebisi Obafemi; Amy Young; Colin Kane
Journal:  Pediatrics       Date:  2011-11-07       Impact factor: 7.124

Review 4.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

Review 5.  Synthetic Cannabinoids.

Authors:  Brooke Mills; Andres Yepes; Kenneth Nugent
Journal:  Am J Med Sci       Date:  2015-07       Impact factor: 2.378

6.  Cannabinoid 1 receptor blockade reduces atherosclerosis with enhances reverse cholesterol transport.

Authors:  Koichi Sugamura; Seigo Sugiyama; Yukio Fujiwara; Junichi Matsubara; Eiichi Akiyama; Hirofumi Maeda; Keisuke Ohba; Yasushi Matsuzawa; Masaaki Konishi; Toshimitsu Nozaki; Yoko Horibata; Koichi Kaikita; Hitoshi Sumida; Motohiro Takeya; Hisao Ogawa
Journal:  J Atheroscler Thromb       Date:  2010-02-03       Impact factor: 4.928

7.  The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets.

Authors:  Engelbert Deusch; Hans Georg Kress; Birgit Kraft; Sibylle A Kozek-Langenecker
Journal:  Anesth Analg       Date:  2004-10       Impact factor: 5.108

Review 8.  A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.

Authors:  Robert J Tait; David Caldicott; David Mountain; Simon L Hill; Simon Lenton
Journal:  Clin Toxicol (Phila)       Date:  2015-11-15       Impact factor: 4.467

9.  Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.

Authors:  Mathias B Forrester; Tracy Haywood
Journal:  Am J Drug Alcohol Abuse       Date:  2012-05-10       Impact factor: 3.829
  9 in total
  4 in total

1.  Brodifacoum-contaminated synthetic marijuana: clinical and radiologic manifestations of a public health outbreak causing life-threatening coagulopathy.

Authors:  Babita Panigrahi; Blake C Jones; Steven P Rowe
Journal:  Emerg Radiol       Date:  2018-07-18

2.  Recurrent STEMI Precipitated by Marijuana Use: Case Report and Literature Review.

Authors:  Perry Wengrofsky; Ghassan Mubarak; Ahmed Shim; Pramod Theetha Kariyanna; Adam Buzidkowski; Jacob Schwartz; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2018

Review 3.  A Literature Review of Cannabis and Myocardial Infarction-What Clinicians May Not Be Aware Of.

Authors:  Kimesh Chetty; Andrea Lavoie; Payam Deghani
Journal:  CJC Open       Date:  2020-09-03

Review 4.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.